complications of tirzepatide Understanding Side Effects, Risks & Treatment Tirzepatide and Semaglutide Most Efficacious

Clinical trials documented mood-related events in less than 1% of semaglutide users, yet patient reports suggest higher real-world prevalence

T2DM: type 2 diabetes mellitus.3.3

For investors, the potential approvals of Donanemab, mRNA-1345, and KarXT could be notable growth catalysts, given their large addressable markets and a historical lack of success in addressing Alzheimer's, RSV, and schizophrenia

MENLO PARK, Calif., April 23, 2025 /PRNewswire/ -- Phenomix Sciences (Phenomix), the first commercial precision obesity medicine biotechnology company, today announced the presentation of 17 groundbreaking studies at Digestive Disease Week (DDW) 2025, taking place May 4-6 in San Diego